Downloads: 4 | Views: 80 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Review Papers | Pharmacotherapeutics | India | Volume 12 Issue 5, May 2023

An Assessment Article on the Cure of Sarcopenia and its Association with type 2 Diabetes in the Elderly

Micah Isaac Anand W

Abstract: Insulin resistance is one of the most frequent absconds within the pathogenesis of type 2 diabetes. Sort 2 Diabetes Mellitus (T2DM), one of the foremost common metabolic clutters, is caused by a combination of two essential components: imperfect insulin emission by pancreatic - cells and the failure of insulin - sensitive tissues to reply suitably to insulin. Sarcopenia, characterised by the misfortune of skeletal muscle mass and quality, has become a common trademark of maturing and numerous incessant maladies. Diabetes mellitus patients have the next predominance of sarcopenia, which enormously irritates the metabolic unsettling influence and compromises the treatment reaction. Preclinical and clinical studies have shown differential impacts of anti - diabetic drugs on skeletal muscle mass, quality, and execution, highlighting the importance of a sound, accommodating regimen from the point of view of sarcopenia danger. The coexistence of these circumstances compounds the worries of elderly patients. In this paper, we audit the most effective measures for the avoidance and administration of sarcopenia and/or slightness in elderly patients with T2DM.

Keywords: Type 2 diabetes mellitus, sarcopenia, weight loss in type 2 diabetes patient, anti - diabetic drugs induced sarcopenia, pharmacotherapy of type 2 diabetes with sarcopenia

Edition: Volume 12 Issue 5, May 2023,

Pages: 1365 - 1376